Researchgate profileJulie HENRIQUES is a research engineer in biostatistics. She passed in 2010 a master’s degree in statistical modeling at the University of Franche-Comté. During the master’s degree’s internship in the biostatistics service of the Hospices Civils of Lyon, she realized a study on the correction of survival estimates in the context of loss to follow-up in HIV cohort . She worked as independent statistician for 5 years and participated to projects in many area such as financial times series, reservoir computing or EEG signal processing.
In 2015, she joined the Methodology and quality of life unit in Oncology (UMQVC) at the University hospital of Besancon.
Latest publications
Highlights•First real-world multicentre data on adjuvant capecitabine in resected biliary tract cancer.•Capecitabine...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : JHEP Reports
Highlights•Dual CTLA-4/PD-1 was associated with improved progression-free survival and overall survival versus...
Posted by : Dr. Dewi VERNEREY, Mme. Julie HENRIQUES
Journal name : Clinical Colorectal Cancers and Other Gastrointestinal Malignancies
AbstractOverview of biliary tract cancer management practices in France: results of the ACABi national survey...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Bull Cancer
01
2020, February
AbstractBackground: The use of absorbable meshes during contaminated or infected incisional hernia (IH) repair is...
Posted by : Mme. Julie HENRIQUES
Journal name : J Gastrointest Surg
AbstractBackground: We evaluated the value of pre-treatment positron-emission tomography-computed tomography...
Posted by : Mme. Julie HENRIQUES, Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Cancers (Basel)
AbstractPurpose: In patients with resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma, surgery plus...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Journal of Clinical Oncology
AbstractPurpose: This prospective pharmacokinetic (PK) ancillary study of the TEXCAN phase II GERCOR trial of...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : European journal of cancer
AbstractHigh-risk HPV (hrHPV) testing has been implemented as a primary screening tool for cervical cancer in numerous...
Posted by : Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, Mme. Julie HENRIQUES
Journal name : Cancers (Basel)
AbstractBackground: Failed kidney transplant is becoming a frequent cause of dialysis initiation. Although studies...
Posted by : Mme. Julie HENRIQUES, Dr. Dewi VERNEREY
Journal name : Nephrol Dial Transplant
AbstractObjective: To evaluate the effects of switching from prednisone (P) to dexamethasone (D) at asymptomatic...
Posted by : Mme. Julie HENRIQUES, Pr. Franck BONNETAIN
Journal name : BJU Int